GoodRx Holdings, Inc. <GDRX.O>: UBS raises target price to $3.75 from $2.5
GDRX•Related News
Nucor to invest $59 million to expand Vulcraft Indiana plant, add steel grating production
NUE•
Cytokinetics sues Bristol Myers, MyoKardia seeking ruling on MYQORZO patent dispute
CYTK•
Spotify And Kobalt Announce Licensing Agreement For Fan-Made Covers And Remixes
SPOT•
U.S. Research Roundup-Airbnb, Five Below, Silgan Holdings
ABNB•
Ideal Power Q2 FY26 net loss narrows to $3.41 million; revenue more than quadruples to $5,800
IPWR•